MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis

BACKGROUND: Tamoxifen is the drug of choice for treating breast cancer, particularly the estrogen receptor-positive luminal A subtype. However, the increased occurrence of Tamoxifen resistance highlights the need to develop an agent to enhance the effectiveness of this drug. OBJECTIVE: Although glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzahra, Salma Nur Azizah, Hanif, Naufa, Hermawan, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727350/
https://www.ncbi.nlm.nih.gov/pubmed/35901340
http://dx.doi.org/10.31557/APJCP.2022.23.7.2341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727350/
https://www.ncbi.nlm.nih.gov/pubmed/35901340
http://dx.doi.org/10.31557/APJCP.2022.23.7.2341

Ejemplares similares